COVID-19-related health anxieties and impact of specific interventions in patients with inflammatory bowel disease in the UK.
IBD
IBD clinical
Journal
Frontline gastroenterology
ISSN: 2041-4137
Titre abrégé: Frontline Gastroenterol
Pays: England
ID NLM: 101528589
Informations de publication
Date de publication:
2021
2021
Historique:
received:
27
07
2020
revised:
23
08
2020
accepted:
30
08
2020
entrez:
27
4
2021
pubmed:
28
4
2021
medline:
28
4
2021
Statut:
epublish
Résumé
Health-related concerns brought on by the COVID-19 pandemic and the impact of specific local and national interventions have not been explored in patients with inflammatory bowel disease (IBD) in the UK. We evaluated perspectives of patients with IBD on the pandemic and effectiveness of information dissemination in addressing concerns. We prospectively conducted a survey among patients with IBD during the COVID-19 pandemic to assess concerns, information-seeking behaviours, risk perception, compliance and effect of specific interventions. A total of 228 patients were interviewed of whom 89% reported being concerned about the impact of COVID-19 on their health. Access to at least one IBD-specific clinical interaction during the pandemic (COVID-19 information letter from IBD team, interaction with IBD team or general practitioner, Crohn and Colitis UK website visit) was significantly associated with alleviating concerns (OR 2.66; 95% CI 1.35 to 5.24; p=0.005). Seeking health information solely through unofficial channels (search engines or social media) was less likely to ease concerns (OR 0.15; 95% CI 0.03 to 0.61; p=0.008). A quarter of patients disagreed with their assigned risk groups, with majority perceiving higher-risk profiles. This discordance was greatest in patients within the moderate-risk group and constituted immunosuppression use. Nearly 40% of patients had ongoing concerns with regard to their medications of whom a third felt their concerns were not addressed. IBD-specific clinical interactions are associated with alleviation of COVID-19 health concerns. These findings have wider implications and emphasise importance of innovative solutions that facilitate effective communication with patients without overburdening current services.
Identifiants
pubmed: 33903816
doi: 10.1136/flgastro-2020-101633
pii: flgastro-2020-101633
pmc: PMC7488739
doi:
Types de publication
Journal Article
Langues
eng
Pagination
200-206Informations de copyright
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Lancet Psychiatry. 2020 Apr;7(4):e21
pubmed: 32199510
New Sci. 2020 Apr 25;246(3279):11
pubmed: 32372822
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525-527
pubmed: 32311321
EClinicalMedicine. 2020 Jun 03;23:100404
pubmed: 32632416
Gastroenterology. 2020 Aug;159(2):481-491.e3
pubmed: 32425234
Aliment Pharmacol Ther. 2020 Sep;52(5):937-939
pubmed: 32852808
Lancet Respir Med. 2020 Jun;8(6):547-548
pubmed: 32401711
Aliment Pharmacol Ther. 2020 May;51(10):922-934
pubmed: 32237083
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):253-255
pubmed: 32214232
Frontline Gastroenterol. 2020 Jun 16;11(5):343-350
pubmed: 32874484
J Crohns Colitis. 2020 Jun 20;:
pubmed: 32564068
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):631-632
pubmed: 32411920
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):639-640
pubmed: 32442546
Gut. 2020 Jun;69(6):984-990
pubmed: 32303607